-
1 Comment
Seneca Growth Capital VCT is currently in a long term uptrend where the price is trading 23.7% above its 200 day moving average.
From a valuation standpoint, the stock is 93.2% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 3.6.
Seneca Growth Capital VCT's total revenue sank by 0.0% to $260K since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-268K since the same quarter in the previous year.
Finally, its free cash flow fell by 161.4% to $-47K since the same quarter in the previous year.
Based on the above factors, Seneca Growth Capital VCT gets an overall score of 2/5.
| ISIN | GB0031256109 |
|---|---|
| Industry | |
| Exchange | LSE |
| CurrencyCode | GBP |
| Sector |
| Beta | 0.25 |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Market Cap | 13M |
| Dividend Yield | None |
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HYG.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
